After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...

Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

Large language models (LLMs) sometimes lose confidence when answering questions and abandon correct answers, according to a ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Scientists unite to warn that a critical window for monitoring AI reasoning may close forever as models learn to hide their thoughts.

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Google on Thursday announced the second cohort to take part in its AI Academy: American Infrastructure, which seeks to ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

This AI system can analyze up to one million DNA letters at once, predicting how tiny changes in noncoding regions trigger ...